Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Groothuis

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Breast Cancer Research and Treatment|June 24, 2023
Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analyticsDave T Hamersma, Kay Schreuder, Gijs Geleijnse, et al.
Critical Care Medicine|March 9, 2000
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitroM W Nijsten, P Olinga, T H The, et al.
The European Respiratory Journal|August 16, 2019
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trialAnke Lenferink, Job van der Palen, Paul D L P M van der Valk, et al.
Breast Cancer Research and Treatment|July 20, 2012
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrencesAnnemiek B G Kwast, Karin C G M Groothuis-Oudshoorn, Ilse Grandjean, et al.
Journal of Extracellular Biology|July 1, 2024
Towards IVDR-compliance by implementing quality control steps in a quantitative extracellular vesicle-miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphomaEsther E E Drees, Nils J Groenewegen, Sandra A W M Verkuijlen, et al.
Cancers|August 27, 2021
Preferences of Treatment Strategies among Women with Low-Risk DCIS and OncologistsDanalyn Byng, Valesca P Retèl, Ellen G Engelhardt, et al.
Breast (Edinburgh, Scotland)|November 14, 2024
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapyM C Van Maaren, T A Hueting, D J P van Uden, et al.
International Journal of Cancer|December 12, 2018
Single tube liquid biopsy for advanced non-small cell lung cancerSanne de Wit, Elisabetta Rossi, Sabrina Weber, et al.
Cell Reports. Medicine|September 17, 2025
Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myelomaCristina Gómez-Martín, Esther E E Drees, Monique A J van Eijndhoven, et al.
Journal of Extracellular Vesicles|July 23, 2021
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin LymphomaEsther E E Drees, Margaretha G M Roemer, Nils J Groenewegen, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Breast Cancer Research and Treatment|June 24, 2023
Comparing quality of breast cancer care in the Netherlands and Norway by federated propensity score analyticsDave T Hamersma, Kay Schreuder, Gijs Geleijnse, et al.
Critical Care Medicine|March 9, 2000
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitroM W Nijsten, P Olinga, T H The, et al.
The European Respiratory Journal|August 16, 2019
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trialAnke Lenferink, Job van der Palen, Paul D L P M van der Valk, et al.
Breast Cancer Research and Treatment|July 20, 2012
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrencesAnnemiek B G Kwast, Karin C G M Groothuis-Oudshoorn, Ilse Grandjean, et al.
Journal of Extracellular Biology|July 1, 2024
Towards IVDR-compliance by implementing quality control steps in a quantitative extracellular vesicle-miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphomaEsther E E Drees, Nils J Groenewegen, Sandra A W M Verkuijlen, et al.
Cancers|August 27, 2021
Preferences of Treatment Strategies among Women with Low-Risk DCIS and OncologistsDanalyn Byng, Valesca P Retèl, Ellen G Engelhardt, et al.
Breast (Edinburgh, Scotland)|November 14, 2024
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapyM C Van Maaren, T A Hueting, D J P van Uden, et al.
International Journal of Cancer|December 12, 2018
Single tube liquid biopsy for advanced non-small cell lung cancerSanne de Wit, Elisabetta Rossi, Sabrina Weber, et al.
Cell Reports. Medicine|September 17, 2025
Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myelomaCristina Gómez-Martín, Esther E E Drees, Monique A J van Eijndhoven, et al.
Journal of Extracellular Vesicles|July 23, 2021
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin LymphomaEsther E E Drees, Margaretha G M Roemer, Nils J Groenewegen, et al.
Pageof 13